COPD, Co-morbidities and Health-Related Quality of Life (HRQOL): More is Less

By Divo Miguel  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 3, 2013-06 ,pp. : 275-276

Informa Healthcare

Access to resources Recommend Favorite

Co-morbidities in heart failure

By Deursen Vincent   Damman Kevin   Meer Peter   Wijkstra Peter   Luijckx Gert-Jan   Beek Andre   Veldhuisen Dirk   Voors Adriaan  

Heart Failure Reviews, Vol. 19, Iss. 2, 2014-03 ,pp. : 163-172

Springer Publishing Company

Access to resources Recommend Favorite

The Association of Metabolic Syndrome with Adipose Tissue Hormones and Insulin Resistance in Patients with COPD without Co-morbidities

By Minas Markos   Kostikas Konstantinos   Papaioannou Andriana I.   Mystridou Parthena   Karetsi Eleni   Georgoulias Panagiotis   Liakos Nikolaos   Pournaras Spyros   Gourgoulianis Konstantinos I.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 8, Iss. 6, 2011-12 ,pp. : 414-420

Informa Healthcare

Access to resources Recommend Favorite

Impact of co-morbidities on self-rated health in self-reported COPD: An analysis of NHANES 2001-2008

By Putcha Nirupama  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 3, 2013-06 ,pp. : 324-332

Informa Healthcare

Access to resources Recommend Favorite

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

By Anzueto Antonio   Ferguson Gary   Feldman Greg   Chinsky Kenneth   Seibert Allan   Emmett Amanda   Knobil Katharine   O'Dell Dianne   Kalberg Christopher   Crater Glenn  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 6, Iss. 5, 2009-10 ,pp. : 320-329

Informa Healthcare

Access to resources Recommend Favorite